Black Patients Still Underrepresented in Clinical Trials

Black patients remain underrepresented in US clinical trials despite the Food and Drug Administration's 2015 launch of a 5-year plan to improve the situation, a new study finds.
Reuters Health Information

source https://www.medscape.com/viewarticle/970050?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?